Marketing and processing under the Strategic Partnership Agreement is targeted to start in early April 2017.

Novus is proud to announce its has executed a Strategic Partnership Agreement with AccurateVenture, a leading performance-based marketing company. Novus will now cover the bioRenovate ® Pharmaceutical Grade Hemp Cannabidiol products and the consumer Miracle Brand CBD products, under its Novus MedPlan. The Agreement calls for AccurateVenture to offer its approximate 200,000 customers base the opportunity to purchase the Novus MedPlan giving Novus’ patient members up to a 50% discount off the purchase of any of AccurateVenture’s Cannabidiol products.